Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors
Keywords: انتخابی; SYK; Spleen Tyrosine Kinase; Selective; Potent; Orally bioavailable; Azanaphthyridine; Lead optimisation; Medicinal chemistry;